EraGen Biosciences
And markets molecular reagent products and software for diagnostics and research.
Employees
Enterprise value
$34m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
$34.0m Valuation: $34.0m | Acquisition | ||
| Total Funding | 000k | ||
First Analysis(exited)
Prolog Ventures(exited)
Stonehenge Capital(exited)
Novartis Venture Fund(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads